Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is 0.69x as of 2026-10-06T17:33:02.231Z.
Calculation as of: 2026-10-06T17:33:02.231Z.
Quote observation: 2026-10-06T17:30:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 65e01e2061821370315a71c231e2ba412a336584d38d2dbcbde0d0d1c3e2cd16
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
0.69x
SECTOR MEDIAN · HEALTHCARE
1.56x
median of 738 covered companies
CURRENT VS SECTOR MEDIAN
-55.63%
vs the sector median at left
Mobia Medical, Inc. Common Stock
Market Cap
$303.13M
EV/Assets Ratio
0.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$302.14M
EV/Assets Ratio
0.67x
TTM Avg
2.88x
3Y Avg
2.83x
5Y Avg
2.72x
Market Cap
$311.49M
EV/Assets Ratio
0.81x
TTM Avg
0.97x
3Y Avg
0.80x
5Y Avg
0.97x
Market Cap
$290.35M
EV/Assets Ratio
1.23x
TTM Avg
1.35x
3Y Avg
1.51x
5Y Avg
1.21x
Market Cap
$289.84M
EV/Assets Ratio
0.08x
TTM Avg
0.45x
3Y Avg
0.57x
5Y Avg
0.64x
Market Cap
$319.61M
EV/Assets Ratio
7.51x
TTM Avg
3.53x
3Y Avg
3.32x
5Y Avg
2.88x
Market Cap
$319.69M
EV/Assets Ratio
4.08x
TTM Avg
5.81x
3Y Avg
6.04x
5Y Avg
5.03x
Market Cap
$285.74M
EV/Assets Ratio
0.46x
TTM Avg
1.50x
3Y Avg
0.97x
5Y Avg
0.97x
Market Cap
$321.44M
EV/Assets Ratio
5.13x
TTM Avg
3.45x
3Y Avg
3.55x
5Y Avg
4.17x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mobia Medical, Inc. Common Stock (MOBI) | $303.13M | 0.69x | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $302.14M | 0.67x | 2.88x | 2.83x | 2.72x |
| C4 Therapeutics, Inc. (CCCC)vs › | $311.49M | 0.81x | 0.97x | 0.80x | 0.97x |
| Larimar Therapeutics, Inc. (LRMR)vs › | $290.35M | 1.23x | 1.35x | 1.51x | 1.21x |
| Standard BioTools Inc. (LAB)vs › | $289.84M | 0.08x | 0.45x | 0.57x | 0.64x |
| Avita Medical Inc. (RCEL)vs › | $319.61M | 7.51x | 3.53x | 3.32x | 2.88x |
| ClearPoint Neuro, Inc. (CLPT)vs › | $319.69M | 4.08x | 5.81x | 6.04x | 5.03x |
| Sagimet Biosciences Inc. (SGMT)vs › | $285.74M | 0.46x | 1.50x | 0.97x | 0.97x |
| Sanara MedTech Inc. (SMTI)vs › | $321.44M | 5.13x | 3.45x | 3.55x | 4.17x |
| Indaptus Therapeutics, Inc. (INDP)vs › | $285.02M | 23.15x | 11.49x | 2.95x | 2.04x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
